The Irresistible Future of Natural Gas
Source: Kent Moors, Oil & Energy Investor  (4/8/14)
"After years of being forced to operate the old way, LNG is going to allow for the global movement of natural gas and the establishment of numerous local spot markets." More >

Ted Dixon: What Gold Stock Insider Trading Tells Us
Source: Kevin Michael Grace of The Gold Report  (4/7/14)
Despite the recent big gains in gold stocks, company insiders and institutional investors are still 2.5 times more likely to be buyers than sellers. According to Ted Dixon, cofounder and CEO of INK Research, this shows that those in the know are still quite bullish, despite the pullback in March. In this interview with The Gold Report, Dixon names the top insider buyers by dollar amount and by volume, and explains how investors should interpret this data. More >

What's Abuzz About Gold?
Source: Frank Holmes, U.S. Global Investors  (4/7/14)
"A key driver in gold prices is the real interest rate environment—the real rate of return taking into account the level of inflation." More >

Raymond James' Pavel Molchanov Sees Stars in the Expanding Cleantech Universe
Source: Peter Byrne of The Energy Report  (4/3/14)
Cleantech, an outperformer in the energy space since 2012, experienced a major expansion phase in 2013 that is still unfolding. In this interview with The Energy Report, Raymond James Energy Analyst Pavel Molchanov points to companies with innovative technologies, strong balance sheets and financial flexibility as examples of low risk with high-flying rewards. Find out about his strongest Buy recommendation, as well as a special situation in big oil. More >

Venture Capitalist Ran Nussbaum Brings Big Finance to Little Biotechs
Source: George S. Mack of The Life Sciences Report   (4/3/14)
Biotech companies don't come into the world fully formed. Like most fledglings, they need guidance to grow, prosper and eventually thrive in public markets. Venture capitalist Ran Nussbaum of the Pontifax Group nurtures tiny biotech and medtech startups, finding capital for their growth and maturation. In this interview with The Life Sciences Report, Nussbaum discusses exciting private equity holdings that are close to going public, and makes a case for one public company he knows quite well. More >

How Did High Flyers Turn into Soul Searchers? Maxim Analyst Jason Kolbert on the Highs and Lows of Biotech Valuations
Source: Editors, Streetwise Reports  (4/2/14)
After soaring more than 56% last year, the NASDAQ Biotechnology Index is down almost 15% in March. In this interview with The Life Sciences Report, Jason Kolbert of the Maxim Group points to increased approval rates and a better economic and regulatory environment as the fundamentals behind a revaluation that has occurred in the sector. Kolbert also reflects on recent concerns about pricing and policy changes that have triggered what he considers a normal, healthy correction in an otherwise robust and intact sector. More >

Looking for 1,000% Gains? Resource Investor Oliver Gross Has Some Junior Mining Names for You
Source: Kevin Michael Grace of The Gold Report  (4/2/14)
The bottom is in, declares Oliver Gross of Der Rohstoff-Anleger (The Resource Investor), and the bulls are ready to charge. In this interview with The Gold Report, Gross says that the woefully undervalued juniors will exploit their leverage advantage, with best-in-class companies gaining as much as 500% to 1,000%—or more. And he lists more than a dozen gold, silver and copper companies most likely to soar. More >

Stephan Bogner and the Rise of a Euro-Sino-Russian Superpower
Source: Brian Sylvester of The Mining Report  (4/1/14)
Stephan Bogner, mining analyst with Rockstone Research and CEO of Elementum International, views the crisis in Crimea as the beginning of a larger global power shift east of the Atlantic. In this interview with The Mining Report, Bogner details what these shifting power dynamics will mean for the commodities market. And take heed—gold and silver may continue to make gains, but uranium, potash and rare earths are the true wave of the future. More >

Robert Cohen's Three Drivers for the Gold Price in 2014
Source: Brian Sylvester of The Gold Report  (3/31/14)
Like the rest of the market, Dynamic Funds is being choosy as it shifts cautiously from bullion to equities, in what Vice President and Portfolio Manager Robert Cohen describes as "baby steps." In this interview with The Gold Report, Cohen explains his method of analyzing miners and discusses companies that offer good prospects. More >

Medical Marijuana in Canada: A Growth Industry
Source: Visual Capitalist  (3/30/14)
"With new federal legislation in effect as of April 1, 2014, the market for medical marijuana in Canada is changing drastically." More >

Big Data Goes Hollywood: Alfred Maydorn
Source: Peter Byrne for Streetwise Reports' Special Situations  (3/27/14)
And now a word from Europe: Investment advisor and author Alfred Maydorn publishes the Maydornreport in Kulmbach, Germany, where he researches disruptive high-tech companies with great growth prospects. In this interview with Streetwise Reports' Special Situations, Maydorn reveals his top North American picks in the exponentially expanding media and big data spaces, highlighting firms with low profiles, remarkable products and what look to be explosive futures. More >

Conjuring Profits from Uranium's Resurgence: David Sadowski
Source: Tom Armistead of The Energy Report  (3/27/14)
It doesn't take a Ouija board to predict a rebound in the price of uranium: Global fuel stocks are insufficient, and unmet demand for uranium is growing. In this interview with The Energy Report, David Sadowski, a mining research analyst at Raymond James, explains the forces that will push the price of uranium, and the companies that are likely to benefit. Being selective, he says, will provide the greatest rewards. More >

From Lab Bench to Bedside: David Lowe Brings Common Sense to Neuroscience Investing
Source: George S. Mack of The Life Sciences Report  (3/26/14)
Billions of dollars have been spent chasing molecular targets in neurological diseases that now appear to be worthless. Effective therapies remain rare. But the market is enormous—and low risk—if a company can get a truly workable solution to patients. Consultant and neuroscientist David Lowe, president and CEO of NeuroAssets, helps biotech firms identify targets and find innovative ways to rapidly move drugs into the clinic. In this interview with The Life Sciences Report, Lowe describes one company with exciting preclinical and clinical-stage assets, and advances two more names worthy of investor attention. More >

Jeff Killeen: A Picky Player's Guide to a Cautiously Optimistic Mining Market
Source: Kevin Michael Grace of The Gold Report  (3/26/14)
The price of gold may be enjoying a double-digit increase so far this year and some equities may even have doubled their value, but Jeff Killeen of CIBC World Markets says it's not time to jump into metals with both feet. Be selective, he counsels. In this interview with The Gold Report, Killeen shares the higher-quality names that have prospects for development. More >

CPM Yearbook Says Interest in Gold Equities Reviving as Bear Market Wanes
Source: Dorothy Kosich, Mineweb  (3/26/14)
"While CPM does not expect the gold price to drop significantly from current levels, nor anticipates sharp increases in prices over 2014 and 2015, it does expect that gold equities would be expected to turn higher before the price of gold." More >

Natural Gas Stocks 2014: A Bullish Sign from This LNG Export News
Source: Tara Clarke, Money Morning  (3/26/14)
"U.S. exports of LNG could mitigate any shortages in Europe caused by the Ukraine-Russia conflict." More >

Here's How Russia's Invasion of Crimea Could Benefit Some U.S. Oil Companies
Source: Matt Badiali, The Crux  (3/26/14)
"Companies that can buy oil for $16 or $17 per barrel cheaper can make a much larger profit margin than competitors that must pay more." More >

Mark Lackey: What Happens to a Mine Deferred?
Source: Brian Sylvester of The Mining Report  (3/25/14)
The shuttering of huge copper and iron ore projects gives the Street the blues, but the resulting squeeze in supply can lead to explosive price hikes. Meanwhile, Mark Lackey, executive vice president of CHF Investor Relations, is eyeing infrastructure buildouts in China, Korea, Brazil and India that point to a swelling of demand. In this interview with The Mining Report, find out how Australian partnerships, the deepening of the Panama Canal and the South Korean-Canada trade agreement could result in major returns on investment, and why 2014 looks like a bounce-back year for potash. More >

Brien Lundin: East Meets West in Junior Market Rebound
Source: Brian Sylvester of The Gold Report  (3/24/14)
Can you hear it? Brien Lundin can. It's the sound of the junior resource market mounting a comeback. Lundin, editor of Gold Newsletter, president and CEO of Jefferson Financial and the man behind the New Orleans Investment Conference, traces the rebound to Western speculators coming to the market at the same time that Asian buyers are maintaining a strong level of demand. In this interview with The Gold Report, Lundin pinpoints the fastest horses in his stable of top picks. More >

Is Gold at an Interim Top?
Source: Jordan Roy-Byrne, The Daily Gold  (3/21/14)
"False breakouts usually mark a key turning point." More >

Strong Commodities + Weak Dollar = Canadian Energy Investing Bonanza: Chad Ellison
Source: Brian Sylvester of The Energy Report  (3/20/14)
Chad Ellison of Dundee Capital Markets is gearing up for a red-hot Canadian energy sector. Commodity price strength and weakness in the Canadian dollar are creating a discount in the country's oil and gas explorers and producers. In this interview with The Energy Report, Ellison elaborates on why he's excited to be an energy analyst again, and names companies with strong economics and management teams likely to reward energy investors. More >

Apply Market Savvy to Bear Market Debris; Uncover Biotech Treasures: Cleland and Ireland
Source: George S. Mack of The Life Sciences Report  (3/20/14)
Starting a new investment company and investing in very small biotechs can be a minefield. Because the business is fraught with bad science and liquidity traps, it takes insight and industry experience to ensure investment capital doesn't drop down a foxhole. Roadmap Capital CEO and Founder Hugh Cleland is in the process of negotiating the minefield now. In this interview with The Life Sciences Report, Cleland and Stephen Ireland, Roadmap Capital principal and healthcare partner, discuss five growth names with merit, plus two brief bonus picks. More >

What to Buy for Putin's New War: Nickel Could Surge
Source: Christian DeHaemer, Energy & Capital  (3/20/14)
"If Putin were to cut nickel exports to Europe and the U.S., nickel prices would jump. Prices have already gone up from $6.50/lb to $7.40/lb over the last 30 days." More >

Michael Gray: Is Goldcorp's Bid for Osisko a Harbinger of a Gold Renaissance?
Source: Brian Sylvester of The Gold Report  (3/19/14)
Optimism. Momentum. Buoyancy. Call it what you will, a positive current is running through the gold space. Macquarie Capital Markets' Canadian Mining Equity Research Team Head Michael Gray deconstructs some of the factors contributing to that newfound energy. Calling out merger & acquisition activity as a nascent trend, he shares with The Gold Report some of the names that could be on a senior gold producer's shopping list. More >

Jeb Handwerger: China Isn't Slowing Down, It's Buying Up (Resources, that Is)
Source: Tom Armistead of The Energy Report  (3/18/14)
Headlines about a Chinese economic slowdown may get good web traffic, but the real story is that China is buying up uranium and other resources around the world, says Gold Stock Trades writer Jeb Handwerger. Meanwhile, tensions in Russia highlight the massive country's resource dominance in natural gas, oil, uranium, platinum group metals, rare earths and nickel. Handwerger tells The Mining Report that North America is already acting to develop resources that can meet both domestic and international demand—and this global geopolitical uncertainty is an investment opportunity. More >